Breaking News

Novasep to Build Integrated ADC Facility

Invests €10M to reinforce its bioconjugation services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Novasep plans to invest €10 million to build a fully integrated Antibody Drug Conjugate (ADC) facility at its Le Mans site in France. The new facility will complement its current ADC offering with full bio-conjugation services.   The facility, to be built in 2Q16, will provide contract manufacturing in batch sizes from a few milligrams to 600g to ADC drug developers during clinical trial and commercial development phases.   “Combining chemistry and biology is not a given. Novasep is one of the f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters